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A Rare presentation of neurobrucellosis in a child with
Recurrent transient ischemic attacks and pseudotumor cerebri
(A case report and review of literature)
Abstract
Brucellosis is a multi-system infectious disease that presents with various 
manifestations and complications. Neurobrucellosis is an uncommon but serious 
presentation of brucellosis that can be seen in all stages of the disease. High 
index of suspicion, especially in endemic areas is essential to prevent morbidity 
from this disease.
The case was an 11- year -old female patient who was admitted with a severe 
headache that was worsening over a period of 2 months. The day after each 
attack, she experienced transient right hemiparesia that was lasting less than 
one hour (TIA) as well as blurred vision and bilateral papilledema. Laboratory 
findings revealed serum agglutination Wright test positive at 1/320 and 2ME 
test positive at 1/160. A lumbar puncture showed a clear CSF with increased 
opening pressure (32 cmH2O), CSF examination was within normal range 
(pseudotumor cerebri).To our knowledge, there has been no report for recurrent 
TIA in pediatric neurobrucellosis in the base of pseudotumor cerebri.
In endemic areas like Iran, unexplained neurological signs or symptoms should 
be evaluated for brucellosis.
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CASE REPORT
Introduction
Human brucellosis is a zoonotic granulomatous disease that is endemic in many 
parts of the world, including Middle Eastern and Mediterranean countries.
Humans are affected through the consumption of unpasteurized milk, its products, 
and aerosolization (1,2).
Diverse and non-specific clinical manifestations make the diagnosis difficult. The 
most frequent symptoms are fever, myalgia, malaise, arthralgia, weight loss, and 
night sweats (3).
Neurologic findings of brucellosis occur in less than 5% in adolescents (2,4,5); but 
its prevalence in pediatric is less than 0.8-1% of cases (6,7).
Neurobrucellosis can present with acute or chronic encephalitis, meningitis, 
radiculoneuritis, myelitis, brain abscess, epidural abscess, subarachnoid hemorrhage, 
granuloma, cranial nerve involvement, and neuropsychiatric symptoms (4,5,8,9).
The most frequent presentations of neurobrucellosis are meningoencephalitis 
and meningitis, which can occur early in the course of the disease or as a late 
manifestation (10,11,12).
The other rare manifestations of neurobrucellosis include diabetes insipidus 
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or Brudzinski’s signs, and cranial nerves were intact. 
A decreased force of her right limbs was observed. 
An ophthalmological examination was unremarkable 
except for severe bilateral papilledema that was more 
prominent in the supranasal regions.
Differential diagnoses that were considered for this 
patient were collagen vascular diseases, malignancies, 
mitochondrial disorders, and chronic inflammations.
A rheumatologic profile especially for exclusion of 
systemic lupus erythematosus was requested and it was 
unremarkable.
Hematologic, liver, and renal tests were within normal 
limits. Bone marrow aspiration and a biopsy were 
performed to rule out malignancy and there were no 
pathologic results. A tuberculin test was unremarkable. 
Laboratory findings revealed serum agglutination 
Wright test positive at 1/320 and 2ME test positive at 
1/160.
A lumbar puncture was performed one day after the 
initiation of antibiotic treatment and after a brain MRI 
was performed. It showed a clear CSF with increased 
opening pressure (32 cmH2O). In a CSF examination, 
there were no leukocyte and the protein levels were within 
the normal range. However, increased levels of lactate 
(30 mg/dl, normal range up to 20) and hypoglycorrhachia 
(20 mg/dl, simultaneous blood glucose was 90 mg/ml) 
were noted. Cytology was negative for malignancy. CSF 
serologic tests for brucellosis were positive at 1/20. CSF 
and blood cultures and gram staining were negative. A 
brain MRI with diffusion weighted sequences revealed 
no abnormal results. 
Acetazolamide was administered to decrease the 
patient’s intracranial pressure.
With the view of neurobrucellosis, the patient was 
placed on gentamicin, rifampin, and doxycycline. 
Twenty-eight days after the initiation of the treatment, 
gentamicin was changed to co-trimoxazole. This 
combination was continued for up to 3 months. The 
patient responded well to therapy and hemiparesia, 
aphasia, and visual impairment were resolved without 
any squeals. Serologic tests were repeated 2 weeks later 
and revealed decreasing levels of serum agglutination 
titers to 1/40. One month later, papillary edema was no 
longer detected. 
On a 6 month follow up, there were no reports of relapse.
(13,14), cerebral venous thrombosis (15), Guillain-Barre 
syndrome (16), and subdural hemorrhage (17).
Its mortality rate is 0-5.5% but permanent neurologic 
impairments, especially deafness are common (11). 
Analysis of CSF reveals an elevated protein concentration, 
moderate leukocytosis, and hypoglycorrhachia (10,11). 
CSF and blood cultures can be negative. Thus, the 
diagnosis is made by detecting brucella antibodies in 
CSF. This is diagnostic (18).
We report an 11- year- old female patient with recurrent 
right hemiparesia, severe headaches, transient visual 
impairment, and bilateral papilledema on fundoscopic 
examination that has rarely been reported as a 
manifestation of neurobrucellosis in pediatrics.
Case report
An 11- year- old female patient was hospitalized with 
a severe headache complaint that was worsening over a 
period of 2 months. Frontal headaches were pulsatile and 
were accompanied with photophobia and phonophobia. 
Headaches were fallowed by vomiting and the day 
after, transient right hemiparesia that lasted less than 
one hour. These migraine like attacks, were happening 
twice a week in the previous two month period. Her 
headaches had been treated as migraines and showed no 
improvement. Despite the headaches, she complained of 
transient blurred vision, malaise, weakness, bone pain, 
and weight loss during the same period.
Two weeks before admission to the pediatric 
neurological department, she developed a high nocturnal 
fever, decreased level of consciousness, aphasia, and 
right hemiparesia. She was hospitalized afterward and 
while waiting for laboratory results, treatment started 
with ceftriaxone, vancomycin, and acyclovir.
In spite of responsiveness to the treatment after 3 days 
and increasing level of consciousness, she was referred to 
our department for further evaluation. On the following 
day, she developed recurrent right colonic focal seizures 
and yelling attacks that were controlled by phenytoin.
She had a history of consumption of raw milk products. 
It was also disclosed that her grandfather had been 
treated for brucellosis 3 years ago.
During a general physical examination, she was 
confused but her vital signs were stable. In neurological 
examinations, there was no neck stiffness, no Kernig’s 
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Impermanent blurred vision and diplopia (secondary to 
the abducent nerve dysfunction) may occur (31).
A study in 2007, described a 14- year -old female patient 
with pseudotumor cerebri like presentations. Strabismus 
in associated with bilateral abducent nerve involvement 
and bilateral papilledema were noted. On a follow up 
visit six months later, the patient had no symptoms and 
signs; and papillary edema was relieved (32).
Our patient had transient blurred vision on some days, 
which may be secondary to pseudotumor cerebri. Visual 
impairment and papilledema were resolved one month 
after the initiation of the treatment.
To our knowledge, recurrent TIA, in the base of 
pseudotumor cerebri, has not been reported in pediatric 
neurobrucellosis.
A CSF examination of our patient revealed an increased 
level of lactate and hypoglycorrhachia without any 
pleocytosis or elevated protein.
Habib et al. has reported an 8- year- old male patient with 
brucella meningitis, Jarisch-Herxheimer-like reaction, 
increased CSF lactate, and pleocytosis (7).
Because of parental disagreement, an LP was not 
repeated. Furthermore, there is a report that demonstrated 
persistent hypoglycorrhachia in spite of clinical 
improvement in neurobrucellosis, which may not be 
useful to evaluate response to therapy (33).
In our patient, increasing level of consciousness after 
3 days of treatment with ceftriaxone and vancomycin 
was notable. A high concentration of ceftriaxone in 
CSF may indicate its significant potency against the 
pathogen. Some studies have shown the efficacy of 
adding ceftriaxone to the antibiotic treatment regimen 
of neurobrucellosis. However, our pediatric infectious 
consultant preferred changing ceftriaxone to rifampin, 
doxycycline, and gentamicin.
Erdem et al. showed ceftriaxone based protocols are 
more successful than oral treatment regimens for 
neurobrucellosis (34). Gul et al. reported successful 
management of neurobrucellosis with ceftriaxone in 
seven patients (3).
Even though, there is not enough data regarding 
the routine use of ceftriaxone in the management of 
CNS brucellosis, it seems to be practical for pediatric 
neurobrucellosis.
In conclusion, diagnosis is difficult because of the 
Discussion
The main clinical presentations of neurobrucellosis in 
pediatrics are demonstrated as meningoencephalitis or 
acute meningitis. Our patient presented with migraine 
like attacks, recurrent hemiparesia, blurred vision, and 
pseudotumor cerebri like manifestations, and, ultimately, 
was hospitalized for acute meningoencephalitis.
In our patient, in addition to the clinical manifestations, 
the diagnosis was confirmed by positive serologic titers 
for brucella in serum and CSF.
Salih researched the inflammatory risk factors of pediatric 
stroke and only 2out of 18 children were observed to have 
neurobrucellosis that presented with left hemiparesia 
and left facial nerve palsy (19). Sayyahfa et al. have also 
reported a nine- year- old female patient with sudden 
onset of hemiparesis and aphasia that recovered after 
one month (20).
It has been proposed that TIA in neurobrucellosis may 
be due to cerebral vasospasm, infectious vasculitis, or 
thromboembolism (9,21,22,23).
Our patient had recurrent migraine like headaches 
followed by hemiparesia that occurred a day after and 
lasted less than 1 hour. These transient ischemic attacks 
were repeated more than 10 times in the previous 2 
month period and they were misdiagnosed as migraine 
headaches. According to the normal results of MRI that 
was performed between attacks, probably the TIA in our 
patient was due to thromboembolism.
In the literature, the association of optic neuropathy and 
pediatric neurobrucellosis is a rare complication (24,12). 
Ischemic vasculitis and inflammatory changes in the 
optic nerve may explain the presence of secondary optic 
neuropathy in neurobrucellosis (24).
Rare visual manifestations of neurobrucellosis in children 
that were published in the literature were bilateral and 
unilateral blindness (24,26), optic neuritis (27), gradual 
loss of vision, and diplopia (28).
Papilledema has been reported in neurobrucellosis. 
Both optic neuritis and pseudotumor cerebri have been 
involved in its pathophysiology (9, 29).
Optic neuritis characterized by papilledema, painful 
eye movements, quick loss of visual acuity, and relative 
afferent pupillary defect (30). Pseudotumor cerebri 
presents as papilledema, increased CSF pressure, but 
generally preserved vision and pupillary reflexes. 
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